Vintage Drug Atop Loop Diuretics Boosts ADHF Decongestion: ADVOR

Adding the IV drug to loop diuretics in the ADVOR trial improved decongestion success in volume-overloaded patients with acute decompensated heart failure, researchers reported.

Related Keywords

Genk ,Region Flamande ,Belgium ,University Of Texas Southwestern Medical Center ,Texas ,United States ,North Carolina ,Boston ,Massachusetts ,Dallas ,Spain ,Duke University ,Barcelona ,Comunidad Autonoma De Cataluna ,Belgian ,Wilfried Mullens ,Markh Drazner ,Bristol Myers Squibb ,G Michael Felker ,European Society Of Cardiology Congress ,Duke University School Of Medicine ,Abbott Fund ,Belgian Health Care Knowledge Center ,Boehringer Ingelheim ,Boston Scientific ,Novartis ,Astrazeneca ,European Society Of Cardiology ,Medtronic ,Hospital Oost Limburg ,European Society ,Decompensated Heart Failure ,Volume Overload ,New England Journal ,Texas Southwestern Medical Center ,Duke University School ,Belgian Health Care Knowledge ,Cardiology Congress ,Online Session ,Acute Heart ,Presented August ,Acute Heart Failure ,Acute Hf ,Diuretics ,Hypertension ,Congestive Heart Failure ,Bedema ,Heart Failure ,Ascites ,Hospitals ,Inpatient Care ,Sglt2 Inhibitors ,Odium Glucose Transporter 2 Inhibitors ,Odium Glucose Co Transporter 2 Inhibitors ,Sodium Glucose Cotransporter 2 Inhibitors ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Adhd ,Ttention Deficit Hyp ,